OTC Division Deputy Director Katz Leaving To Head Cosmetics, Colors Office
This article was originally published in The Tan Sheet
Executive Summary
FDA Division of OTC Drugs Deputy Director Linda Katz, MD, will take over the Office of Cosmetics & Colors Sept. 3, according to the Center for Food Safety & Applied Nutrition
You may also be interested in...
FTC Telemarketer User Fee Proposal Based Upon Area Codes
The Federal Trade Commission intends to charge telemarketers an annual fee of $12 per area code of data used from a national "Do Not Call" registry
FDA's New OTC Drugs Director Ganley Brings Cardio-Renal Background To Job
Charles Ganley, MD, the new director of FDA's Division of OTC Drugs, brings to the post a background as an agency medical reviewer in the Division of Cardio-Renal Drug Products, where he has worked since 1989. He will report to Office of Drug Evaluation V Director Robert DeLap, MD/PhD.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC